Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 601

Similar articles for PubMed (Select 17264955)

1.

Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.

Fernandez-L A, Garrido-Martin EM, Sanz-Rodriguez F, Ramirez JR, Morales-Angulo C, Zarrabeitia R, Perez-Molino A, Bernabéu C, Botella LM.

Thromb Haemost. 2007 Feb;97(2):254-62.

PMID:
17264955
2.

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.

Albiñana V, Bernabeu-Herrero ME, Zarrabeitia R, Bernabéu C, Botella LM.

Thromb Haemost. 2010 Mar;103(3):525-34. doi: 10.1160/TH09-07-0425. Epub 2010 Feb 2.

PMID:
20135064
3.

[Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].

Morales-Angulo C, Pérez del Molino A, Zarrabeitia R, Fernández A, Sanz-Rodríguez F, Botella LM.

Acta Otorrinolaringol Esp. 2007 Apr;58(4):129-32. Spanish.

4.

Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.

Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, Pérez-Molino A, Hebbel RP, Nguyen J, Bernabéu C, Botella LM.

Cardiovasc Res. 2005 Nov 1;68(2):235-48. Epub 2005 Jul 5.

5.

Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.

Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C.

J Cell Physiol. 2005 Aug;204(2):574-84.

PMID:
15702480
6.
7.

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.

Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K.

J Cell Physiol. 2002 Dec;193(3):299-318.

PMID:
12384983
9.

Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.

Azuma H.

J Med Invest. 2000 Aug;47(3-4):81-90. Review.

PMID:
11019486
10.

Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.

Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabeu C, Letarte M.

Hum Mol Genet. 2000 May 1;9(8):1227-37.

12.

Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.

Scherner O, Meurer SK, Tihaa L, Gressner AM, Weiskirchen R.

J Biol Chem. 2007 May 11;282(19):13934-43. Epub 2007 Mar 21.

13.

Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.

Lenato GM, Suppressa P, Giordano P, Guanti G, Guastamacchia E, Triggiani V, Amati L, Resta F, Covelli V, Jirillo E, Sabbà C.

Curr Pharm Des. 2007;13(36):3656-64.

PMID:
18220803
14.

Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.

Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL.

Development. 2004 Dec;131(24):6237-47. Epub 2004 Nov 17.

15.

Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro.

Tian F, Zhou AX, Smits AM, Larsson E, Goumans MJ, Heldin CH, Borén J, Akyürek LM.

Biochem Biophys Res Commun. 2010 Feb 12;392(3):283-8. doi: 10.1016/j.bbrc.2009.12.170. Epub 2010 Jan 10.

PMID:
20060813
17.

Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.

Letarte M, McDonald ML, Li C, Kathirkamathamby K, Vera S, Pece-Barbara N, Kumar S.

Cardiovasc Res. 2005 Oct 1;68(1):155-64.

18.

Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.

Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W, Marchuk D, Guttmacher A.

J Med Genet. 2003 Aug;40(8):585-90.

19.

Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.

Fernández-L A, Sanz-Rodriguez F, Blanco FJ, Bernabéu C, Botella LM.

Clin Med Res. 2006 Mar;4(1):66-78. Review.

20.

Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis.

van den Driesche S, Mummery CL, Westermann CJ.

Cardiovasc Res. 2003 Apr 1;58(1):20-31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk